Total Funding
64
63
Total FundingGrant raised
Growth Score 64 in past quarter
-24 pts
Heat Score 63 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
168066
Estrigenix is a new pharmaceutical company specializing in oestrogen biology.
About the Company
Estrigenix Therapeutics, Inc. is a privately held pharmaceutical company focused on developing the next generation of innovative therapies to improve menopausal women's mental health. Estrigenix Therapeutics was formed in 2018 to improve women’s health, focusing initially on the physical and mental effects of menopause.
